• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Emerg Infect Dis . Two-Year Cohort Study of SARS-CoV-2, Verona, Italy, 2020‒2022

tetano

Editor, Senior Moderator
Emerg Infect Dis


. 2023 Mar 14;29(4).
doi: 10.3201/eid2904.221268. Online ahead of print.
Two-Year Cohort Study of SARS-CoV-2, Verona, Italy, 2020‒2022

Zeno Bisoffi, Nicoletta De Santis, Chiara Piubelli, Michela Deiana, Francesca Perandin, Pietro Girardi, Luca Heller, Natalia Alba, Carlo Pomari, Massimo Guerriero

Abstract

We performed a follow-up of a previously reported SARS-CoV-2 prevalence study (April‒May 2020) in Verona, Italy. Through May 2022, only <1.1% of the city population had never been infected or vaccinated; 8.8% was the officially reported percentage. Limiting protection measures and vaccination boosters to elderly and frail persons seems justified.

Keywords: COVID-19; Italy; SARS-CoV-2; Verona; cohort study; coronavirus disease; coronaviruses; cumulative incidence; elderly; frail persons; incidence; pandemic; prevalence; reported data; respiratory infections; sampling data; serologic testing; vaccine; viruses; zoonoses.
 
Back
Top Bottom